Diamond Hill Capital Management, LLC has filed its Form 13F-HR report for the period ending September 30, 2026. The filing details the firm's equity portfolio holdings as of the close of the third quarter.
The report lists 172 separate equity positions held by the firm. The largest holding disclosed in the filing is Abbott Laboratories, for which Diamond Hill reported ownership of 2,008,269 shares. The firm also holds significant positions in Amazon.com, Inc. (1,564,534 shares) and ConocoPhillips (1,545,544 shares).
The portfolio includes a mix of technology, healthcare, and energy companies. Major technology holdings include Microsoft Corp. (1,074,625 shares) and Meta Platforms, Inc. (457,928 shares). Healthcare names such as Medtronic PLC (1,485,743 shares) and Thermo Fisher Scientific, Inc. (219,899 shares) are also listed. In the energy sector, the firm holds positions in Devon Energy Corp. (648,360 shares) and Diamondback Energy, Inc. (1,244,091 shares).
The filing indicates that Diamond Hill Capital Management acts as the investment advisor for the report. The firm's principal executive office is located at 325 John H. McConnell Blvd. Suite 200, Columbus, OH 43215. Alyssa Bentz, Chief Compliance Officer, is listed as the contact person for the filing.
